source; lin
  • Sirona Biochem (SBM) terminates supply agreement with Rodan + Fields
  • Allergan Aesthetics will now be the sole licensee of the technology as per the agreement signed in June 2022
  • There may be potential for more news to be released regarding this termination at a later date
  • Sirona Biochem is a cosmetic ingredient and drug discovery company with proprietary platform technology
  • The company strives to patent new compounds for maximum revenue potential
  • Sirona Biochem (SBM) is up 23.81 per cent, trading at C$0.13 at 1:57 pm EST

Sirona Biochem (SBM) has terminated the Rodan + Fields (R+F) agreement for the supply and use of TFC-1067 in commercial formulations.

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), will now be the sole licensee of the technology as per the agreement signed in June 2022.

There may be more news regarding the termination at a later date.

Sirona Biochem is a cosmetic ingredient and drug discovery company with proprietary platform technology.

Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety.

The company strives to patent new compounds for maximum revenue potential.

Sirona Biochem (SBM) is up 23.81 per cent, trading at C$0.13 at 1:57 pm EST.


More From The Market Online
Docebo Inc. - CEO, Claudio Erba

Docebo stock rallies on 2023 financial report

Software firm Docebo (TSX:DCBO) reported its Q4 and fiscal year 2023 financial results above analysts’ estimates.

FaZe Clan stockholders approve GameSquare merger

FaZe Holdings Inc. (NASDAQ:FAZE) announced that its stockholders have voted to approve the proposed merger with GameSquare (NASDAQ:GAME).

Zonte Metals discovers large copper-in-soil anomalies in Newfoundland

Zonte Metals (TSXV:ZON) has discovered copper-in-soil anomalies at its Cross Hills Copper Project in Newfoundland.

Clearmind Medicine to begin alcohol use disorder clinical trial

Clearmind Medicine (CSE:CMND) has received approval to begin its phase I/IIa clinical trial for alcohol use disorder in Israel.